Cargando…
Epigenetic drug screen identified IOX1 as an inhibitor of Th17-mediated inflammation through targeting TET2
BACKGROUND: Targeting helper T cells, especially Th17 cells, has become a plausible therapy for many autoimmune diseases. METHODS: Using an in vitro culture system, we screened an epigenetics compound library for inhibitors of IFN-γ and IL-17 expression in murine Th1 and Th17 cultures. FINDINGS: Thi...
Autores principales: | Hu, Xiao, Zou, Yanli, Copland, David A., Schewitz-Bowers, Lauren P., Li, Yan, Lait, Philippa J.P., Stimpson, Madeleine, Zhang, Zhihui, Guo, Shixin, Liang, Juanran, Chen, Tingting, Li, Jing Jing, Yuan, Sujing, Li, Shuo, Zhou, Penghui, Liu, Yizhi, Dick, Andrew D., Wen, Xiaofeng, Lee, Richard W.J., Wei, Lai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646865/ https://www.ncbi.nlm.nih.gov/pubmed/36335665 http://dx.doi.org/10.1016/j.ebiom.2022.104333 |
Ejemplares similares
-
Re-programming immunosurveillance in persistent non-infectious ocular inflammation
por: Epps, Simon J., et al.
Publicado: (2018) -
The DNA Methylation Inhibitor Zebularine Controls CD4(+) T Cell Mediated Intraocular Inflammation
por: Zou, Yanli, et al.
Publicado: (2019) -
Ex Vivo T Cell Cytokine Expression Predicts Survival in Patients with Severe Alcoholic Hepatitis
por: Dhanda, Ashwin D., et al.
Publicado: (2020) -
Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
por: Liu, Jing, et al.
Publicado: (2021) -
IOX1 impedes host inflammation in imiquimod-triggered psoriasis
por: Shin, Joo Eun, et al.
Publicado: (2021)